437 related articles for article (PubMed ID: 15119110)
41. Prenatal screening tests facilitate risk assessment.
Miller SM; Isabel JM
MLO Med Lab Obs; 2002 Feb; 34(2):8-11, 14-6, 19; quiz 20-1. PubMed ID: 11881274
[TBL] [Abstract][Full Text] [Related]
42. Factors affecting women's preference for type of prenatal screening test for chromosomal anomalies.
Spencer K; Aitken D
Ultrasound Obstet Gynecol; 2004 Dec; 24(7):735-9. PubMed ID: 15505874
[TBL] [Abstract][Full Text] [Related]
43. [Prenatal screening and diagnostics after infertility treatment].
Gjerris AC; Loft A; Pinborg AB; Christiansen M; Tabor A
Ugeskr Laeger; 2007 Jan; 169(5):414-9. PubMed ID: 17280635
[TBL] [Abstract][Full Text] [Related]
44. Integrated screening for Down's syndrome.
Reynolds T; Zimmermann R; Wright E
N Engl J Med; 1999 Dec; 341(25):1935; author reply 1936. PubMed ID: 10610478
[No Abstract] [Full Text] [Related]
45. Sequential and contingent prenatal screening for Down syndrome.
Wald NJ; Rudnicka AR; Bestwick JP
Prenat Diagn; 2006 Sep; 26(9):769-77. PubMed ID: 16821246
[TBL] [Abstract][Full Text] [Related]
46. Follow up and evaluation of the Victorian first-trimester combined screening programme for Down syndrome and trisomy 18.
Jaques AM; Halliday JL; Francis I; Bonacquisto L; Forbes R; Cronin A; Sheffield LJ
BJOG; 2007 Jul; 114(7):812-8. PubMed ID: 17501960
[TBL] [Abstract][Full Text] [Related]
47. First trimester screening for Down syndrome in multiple pregnancy.
Cleary-Goldman J; Berkowitz RL
Semin Perinatol; 2005 Dec; 29(6):395-400. PubMed ID: 16533653
[TBL] [Abstract][Full Text] [Related]
48. Repeated measurement of pregnancy-associated plasma protein-A (PAPP-A) in Down syndrome screening: a validation study.
Palomaki GE; Wright DE; Summers AM; Neveux LM; Meier C; O'donnell A; Huang T; Knight GJ; Haddow JE
Prenat Diagn; 2006 Aug; 26(8):730-9. PubMed ID: 16810709
[TBL] [Abstract][Full Text] [Related]
49. Costs and effects of prenatal screening methods for Down syndrome and neural tube defects.
Hoogendoorn M; Evers SM; Schielen PC; van Genugten ML; de Wit GA; Ament AJ
Community Genet; 2008; 11(6):359-67. PubMed ID: 18690004
[TBL] [Abstract][Full Text] [Related]
50. Three-stage contingent screening for Down syndrome.
Wright D; Bradbury I; Cuckle H; Gardosi J; Tonks A; Standing S; Benn P
Prenat Diagn; 2006 Jun; 26(6):528-34. PubMed ID: 16634118
[TBL] [Abstract][Full Text] [Related]
51. Ethical considerations of early (first vs. second trimester) risk assessment disclosure for trisomy 21 and patient choice in screening versus diagnostic testing.
Sharma G; McCullough LB; Chervenak FA
Am J Med Genet C Semin Med Genet; 2007 Feb; 145C(1):99-104. PubMed ID: 17299736
[TBL] [Abstract][Full Text] [Related]
52. On the current dilemma of Down syndrome screening.
Rose NC
Obstet Gynecol; 2006 Jan; 107(1):2-3. PubMed ID: 16394031
[No Abstract] [Full Text] [Related]
53. Which contingent sequential screening protocol?
Larsen SO; Christiansen M; Norgaard-Pedersen B
Prenat Diagn; 2005 Dec; 25(12):1168-9; author reply 1169-70. PubMed ID: 16317663
[No Abstract] [Full Text] [Related]
54. Screening for trisomy 21 in Flanders: a 10 years review of 40.490 pregnancies screened by maternal serum.
Gyselaers WJ; Vereecken AJ; Van Herck EJ; Straetmans DP; Martens GE; de Jonge ET; Ombelet WU; Nijhuis JG
Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):185-9. PubMed ID: 15262353
[TBL] [Abstract][Full Text] [Related]
55. Stability of first- and second-trimester serum markers after storage and shipment.
Lambert-Messerlian GM; Eklund EE; Malone FD; Palomaki GE; Canick JA; D'Alton ME
Prenat Diagn; 2006 Jan; 26(1):17-21. PubMed ID: 16378319
[TBL] [Abstract][Full Text] [Related]
56. Prenatal detection of birth defects in a Malaysian population: estimation of the influence of termination of pregnancy on birth prevalence in a developing country.
Ho JJ; Thong MK; Nurani NK
Aust N Z J Obstet Gynaecol; 2006 Feb; 46(1):55-7. PubMed ID: 16441696
[TBL] [Abstract][Full Text] [Related]
57. Does vaginal bleeding influence first-trimester markers for Down syndrome?
Heinig J; Steinhard J; Schmitz R; Nofer JR; Witteler R; Mosel A; Ahrens A; Kiesel L; Klockenbusch W
Prenat Diagn; 2007 Apr; 27(4):312-6. PubMed ID: 17286311
[TBL] [Abstract][Full Text] [Related]
58. Integrated screening for Down's syndrome.
Jenkins TM; Wapner RJ
N Engl J Med; 1999 Dec; 341(25):1935; author reply 1936. PubMed ID: 10610477
[No Abstract] [Full Text] [Related]
59. Comparing three screening strategies for combining first- and second-trimester Down syndrome markers.
Palomaki GE; Steinort K; Knight GJ; Haddow JE
Obstet Gynecol; 2006 Feb; 107(2 Pt 1):367-75. PubMed ID: 16449126
[TBL] [Abstract][Full Text] [Related]
60. Integrated, sequential, and contingent screening for Down syndrome - local needs should drive methodology.
Wyatt P
Prenat Diagn; 2007 Feb; 27(2):186-7. PubMed ID: 17266162
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
